Literature DB >> 9298334

Drugged driving, a review based on the experience in Norway.

A S Christophersen1, J Mørland.   

Abstract

Since 1959, the Norwegian Road Traffic Act has prohibited driving under the influence of drugs other than alcohol. On suspicion, the police request a clinical examination from any driver, as well as blood analyses for illegal and prescribed drugs affecting driving performance. During the last few years, there has been a marked increase in the number of drivers suspected of be influenced by drugs (1983, n = 900; 1995, n = 3329). The most commonly detected drugs are tetrahydrocannabinol, amphetamine, benzodiazepines and opiates. Multi-drug use is frequently found (> 60%). The occurrence of amphetamine (1991, n = 216; 1995, n = 937) and heroin (1991, n = 19; 1995, n = 172) has increased considerably. The frequency of drugged drivers apprehended in roadside traffic appears to be at least 10-fold higher in Norway than most other countries. This is probably mainly due to differences between national road traffic acts and the level of attention to the problem, and not to national differences in the prevalence of drugged driving.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9298334     DOI: 10.1016/s0376-8716(97)00081-1

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  6 in total

1.  Drinking, drugs and driving in Ireland: more evidence for action.

Authors:  P Fitzpatrick; L Daly; C P Leavy; D A Cusack
Journal:  Inj Prev       Date:  2006-12       Impact factor: 2.399

2.  Substance-related traffic-risk behaviors among college students.

Authors:  Amelia M Arria; Kimberly M Caldeira; Kathryn B Vincent; Laura M Garnier-Dykstra; Kevin E O'Grady
Journal:  Drug Alcohol Depend       Date:  2011-05-20       Impact factor: 4.492

3.  Heroin-using drivers: importance of morphine and morphine-6-glucuronide on late clinical impairment.

Authors:  Liliana Bachs; Gudrun Høiseth; Svetlana Skurtveit; Jørg Mørland
Journal:  Eur J Clin Pharmacol       Date:  2006-10-05       Impact factor: 2.953

4.  Testing for benzodiazepine inebriation--relationship between benzodiazepine concentration and simple clinical tests for impairment in a sample of drugged drivers.

Authors:  Jørgen G Bramness; Svetlana Skurtveit; Jørg Mørland
Journal:  Eur J Clin Pharmacol       Date:  2003-09-20       Impact factor: 2.953

5.  Codeine and clinical impairment in samples in which morphine is not detected.

Authors:  Liliana Bachs; Svetlana Skurtveit; Jørg Mørland
Journal:  Eur J Clin Pharmacol       Date:  2003-03-01       Impact factor: 2.953

6.  Effects of alcohol (BAC 0.5‰) and ecstasy (MDMA 100 mg) on simulated driving performance and traffic safety.

Authors:  Janet L Veldstra; Karel A Brookhuis; Dick de Waard; Barbara H W Molmans; Alain G Verstraete; Gisela Skopp; Ricarda Jantos
Journal:  Psychopharmacology (Berl)       Date:  2011-11-11       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.